{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:28:58Z","timestamp":1790753338688,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s13730-020-00510-9","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T08:03:49Z","timestamp":1595664229000},"page":"30-34","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A case of latent heterozygous Fabry disease in a female living kidney donor candidate"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9240-0620","authenticated-orcid":false,"given":"Masato","family":"Minami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Mizuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhito","family":"Yoshimine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Mitsuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutoshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Enokida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,25]]},"reference":[{"key":"510_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"27","author":"RO Brady","year":"1967","unstructured":"Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry\u2019s disease. N Engl J Med. 1967;27:1163\u20137.","journal-title":"N Engl J Med"},{"key":"510_CR2","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.167.3922.1268","volume":"167","author":"JA Kint","year":"1970","unstructured":"Kint JA. Fabry\u2019s disease: alpha-galactosidase deficiency. Science. 1970;167:1268\u20139.","journal-title":"Science"},{"key":"510_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;5:30. https:\/\/doi.org\/10.1186\/1750-1172-5-30.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"510_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH, Rowland HS. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet. 2001;38(11):750\u201360.","journal-title":"J Med Genet"},{"issue":"11","key":"510_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH, Rowland HS. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet. 2001;38(11):769\u201375.","journal-title":"J Med Genet"},{"issue":"1\u20132","key":"510_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cccn.2004.10.019","volume":"353","author":"GE Linthorst","year":"2005","unstructured":"Linthorst GE, Vedder AC, Aerts JMFG, Hollak CEM. Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers. Clin Chim Acta. 2005;353(1\u20132):201\u20133.","journal-title":"Clin Chim Acta"},{"issue":"21","key":"510_CR7","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.jacc.2008.02.050","volume":"51","author":"GE Linthorst","year":"2008","unstructured":"Linthorst GE, Poorthuis BJHM, Hollak CEM. Letters to the editor enzyme activity for determination of presence of Fabry disease in women results in 40 % false-negative results. J Am Coll Cardiol. 2008;51(21):2082\u20133.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"510_CR8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s10157-015-1090-6","volume":"19","author":"Y Hoshino","year":"2015","unstructured":"Hoshino Y, Kaga T, Abe Y. Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria. Clin Exp Nephrol. 2015;19(5):918\u201324.","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"510_CR9","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1093\/ndt\/gfp158","volume":"24","author":"A Pierides","year":"2009","unstructured":"Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M, et al. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3 COL4A4 genes associated with famikial hematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2009;24(9):2721\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"510_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jama.2013.285141","volume":"311","author":"AD Muzaale","year":"2014","unstructured":"Muzaale AD, Massie AB, Wan MC, Montgomery RA, McBride MA, Wainright JL, et al. Risk of end-stage renal disease following live kidney donation. JAMA. 2014;311(6):579\u201386.","journal-title":"JAMA"},{"issue":"29","key":"510_CR11","first-page":"2081","volume":"4","author":"JP Gr\u00fcnfeld","year":"1975","unstructured":"Gr\u00fcnfeld JP, Le Porrier M, Droz D, Bensaude I, Hinglais N, Crosnier J. Renal transplantation in patients suffering from Fabry's disease. Kidney transplantation from an heterozygote subject to a subject without Fabry's disease. NouvPresse Med. 1975;4(29):2081\u20135.","journal-title":"NouvPresse Med."},{"issue":"4","key":"510_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000167493","volume":"7","author":"S Popli","year":"1987","unstructured":"Popli S, Molnar ZV, Leehey DJ, Daugirdas JT, Roth DA, Adams MB, et al. Involvement of renal allograft by Fabry's disease. Am J Nephrol. 1987;7(4):316\u20138.","journal-title":"Am J Nephrol"},{"key":"510_CR13","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1034\/j.1600-6143.2003.00139.x","volume":"3","author":"DP Puliyanda","year":"2003","unstructured":"Puliyanda DP, Wilcox WR, Bunnapradist S, Nast CC, Jordan SC. Case report Fabry disease in a renal allograft. Am J Transplant. 2003;3:1030\u20132.","journal-title":"Am J Transplant"},{"key":"510_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/8904_2011_108","volume":"4","author":"LS Paull","year":"2012","unstructured":"Paull LS, Lipinski MJ, Wilson WG, Lipinski SE. Female with Fabry disease unknowingly donates affected kidney to sister: a call for pre-transplant genetic testing. JIMD Rep. 2012;4:1\u20134. https:\/\/doi.org\/10.1007\/8904_2011_108.","journal-title":"JIMD Rep"},{"issue":"1","key":"510_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.transproceed.2012.10.024","volume":"45","author":"S Taneda","year":"2013","unstructured":"Taneda S, Honda K, Nakajima I, Huchinoue S, Oda H. Renal transplantation between siblings with unrecognized Fabry disease. Transplant Proc. 2013;45(1):115\u20138.","journal-title":"Transplant Proc"},{"issue":"4","key":"510_CR16","first-page":"775","volume":"104","author":"R Nishioka","year":"2015","unstructured":"Nishioka R, Sofue T, Moritoki M, Nishijima Y, Nishioka S, Hara T, et al. Case report: a case of living-donor kidney transplantation from a heterozygote mother to a hemizygote son of Fabry disease diagnosed by donated allograft biopsy. Nihon NaikaGakkaiZasshi. 2015;104(4):775\u201380.","journal-title":"Nihon NaikaGakkaiZasshi"},{"issue":"Suppl. 1","key":"510_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/nep.12771","volume":"21","author":"K Odani","year":"2016","unstructured":"Odani K, Okumi M, Honda K, Ishida H, Tanabe K. Kidney transplantation from a mother with unrecognized Fabry disease to her son with low \u03b1-galactosidase A activity: a 14-year follow-up without enzyme replacement therapy. Nephrology. 2016;21(Suppl. 1):57\u20139.","journal-title":"Nephrology"},{"issue":"5","key":"510_CR18","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/ndt\/gfm848","volume":"23","author":"A Ortiz","year":"2008","unstructured":"Ortiz A, Oliveira J, Waldek S, Warnock DG, Cianciaruso B, Wanner C. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy. Nephrol Dial Transplant. 2008;23(5):1600\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"510_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","volume":"10","author":"M Biegstraaten","year":"2015","unstructured":"Biegstraaten M, Arngr\u00edmsson R, Barbey F, Boks L, Cecchi F, Deegan PB, et al. Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document. Orphanet J Rare Diseases. 2015;10:36. https:\/\/doi.org\/10.1186\/s13023-015-0253-6.","journal-title":"Orphanet J Rare Diseases"},{"issue":"3","key":"510_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ymgme.2018.06.004","volume":"124","author":"C Wanner","year":"2018","unstructured":"Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, et al. European expert consensus statement on therapeutic goals in Fabry disease. Mol Genet Metab. 2018;124(3):189\u2013203.","journal-title":"Mol Genet Metab"},{"key":"510_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2012030316","volume":"24","author":"C T\u00f8ndel","year":"2013","unstructured":"T\u00f8ndel C, Bostad L, Larsen KK, Hirth A, Vikse BE, Houge G, et al. Agalsidase benefits renal histology in young patients with Fabry disease. J Am Soc Nephrol. 2013;24:137\u201348.","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 3","key":"510_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10545-010-9136-0","volume":"33","author":"A Tanaka","year":"2010","unstructured":"Tanaka A, Takeda T, Hoshina T, Fukai K, Yamano T. Enzyme replacement therapy in a patient with Fabry disease and the development of IgE antibodies against agalsidase beta but not agalsidase alpha. J Inherit Metab Dis. 2010;33(Suppl 3):249\u201352.","journal-title":"J Inherit Metab Dis"},{"key":"510_CR23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/jmedgenet-2016-104178","volume":"54","author":"DA Hughes","year":"2017","unstructured":"Hughes DA, Nicholls K, Shankar SP, Sunder-Plassmann G, Koeller D, Nedd K. Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. J Med Genet. 2017;54:288\u201396.","journal-title":"J Med Genet"},{"issue":"1","key":"510_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/4801","volume":"5","author":"JQ Fan","year":"1999","unstructured":"Fan JQ, Ishii S, Asano N, Suzuki Y. Accelelated transport and maturation of lysosomal \u03b1\u2013galactosidase A in Fabrylymphoblasts by an enzyme inhibitor. Nat Med. 1999;5(1):112\u20135.","journal-title":"Nat Med"},{"issue":"1","key":"510_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1096\/fj.04-2375com","volume":"19","author":"GH Yam","year":"2005","unstructured":"Yam GH, Zuber C, Roth J. A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder. FASEB J. 2005;19(1):12\u20138.","journal-title":"FASEB J."},{"issue":"13","key":"510_CR26","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1046\/j.1432-1327.2000.01457.x","volume":"267","author":"N Asano","year":"2000","unstructured":"Asano N, Kizu H, Ikeda K, Yasuda K, Ishii S, Martin OR, et al. In vitro inhibition and intracellular enhancement of lysosomal \u03b1-galactosidasea activity in fabrylymphoblasts by 1-deoxygalactonojirimycin and its derivatives. Eur J Biochem. 2000;267(13):4179\u201386.","journal-title":"Eur J Biochem"},{"issue":"7","key":"510_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s10038-019-0599-z","volume":"64","author":"M Kobayashi","year":"2019","unstructured":"Kobayashi M, Ohashi T, Kaneshiro E, Higuchi T, Ida H. Mutation spectrum of \u03b1-galactosidase gene in Japanese patients with Fabry disease. J Hum Genet. 2019;64(7):695\u20139.","journal-title":"J Hum Genet"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00510-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-020-00510-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00510-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T23:06:09Z","timestamp":1627167969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-020-00510-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,25]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["510"],"URL":"https:\/\/doi.org\/10.1007\/s13730-020-00510-9","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,25]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}